Investor Relations · Boards & AGM
Management Board
The people leading Novogenia AG.
Management Board
The people leading Novogenia AG.
Dr. Daniel Wallerstorfer PhD, BSc
Molecular biologist with a PhD in Biotechnology and founder of Novogenia. Daniel built the company into a leading laboratory for genetic testing and personalized health, driving the Group’s research, technology and product innovation. During the COVID-19 pandemic the group became a leading SARS-CoV-2 testing laboratory, and the holding company was listed on the Munich Stock Exchange. He is also a science author who educates the public about the power of our genes.
Felix Bausch
Member of the Management Board, leading Investor Relations and Mergers & Acquisitions for the Group from Munich — managing the capital-market relationships and the acquisition pipeline that drive Novogenia’s growth strategy.
Matthias Probst Mag. (FH)
Co-founder of Novogenia GmbH and Chief Financial Officer of the Group. Matthias oversees finance across the holding and its operating companies, providing the financial foundation for the Group’s expansion.